Variations in the consumption of mental health medications in a brazilian primary care unit: is there influence of the pandemic?
DOI:
https://doi.org/10.30827/ars.v65i2.29775Keywords:
Primary Health Care, Pharmaceutical Services, Special Control Medications, COVID-19Abstract
Introduction: The COVID-19 pandemic has generated the need for adjustments and adaptations in various areas, from behaviour to regulations, with significant repercussions in terms of public health.
Objective: To compare the monthly average consumption (MAC) of special control medications used for mental health before and during the pandemic in a Basic Health Unit (UBS) in the Federal District, Brazil.
Methods: Consumption data were obtained through the local inventory management system, and the MAC (±standard deviation) was calculated excluding months of stockouts, considering the period from 2020 to 2022. The MAC±SD of 2019 was used as a comparative parameter.
Results: Consumption of 32 medications was analyzed, with the majority being antiepileptics (N=10; 31.2 %), antidepressants (N=10; 31.2 %), and antipsychotics (N=8; 25.0 %). It was observed that more than half of the analyzed medications (n=18; 56.3 %) maintained an increase in consumption throughout the pandemic years.
Conclusion: There was a significant variation in the consumption of special control medications at the UBS during the pandemic. These results may be associated with various factors, such as the increase in clinical conditions justifying their prescription, in line with current literature on the potential impact of social isolation and measures taken by competent authorities to contain the spread of the SARS-CoV-2 virus.
Downloads
References
Joshi G, Borah P, Thakur S, Sharma P, Mayank, Poduri R. Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go? Vol. 17, Hum Vaccin Immunother.; 2021. p. 4714–40. Doi: 10.1080/21645515.2021.1995283 DOI: https://doi.org/10.1080/21645515.2021.1995283
Word Health Organization (WHO). Mental health and COVID-19: early evidence of the pandemic’s impact: scientific brief, 2 March 2022 [Internet]. 2022. Disponible en: https://apps.who.int/iris/handle/10665/352189
Santomauro DF, Mantilla Herrera AM, Shadid J et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021;398(10312):1700–12. Doi: 10.1016/S0140-6736(21)02143-7 DOI: https://doi.org/10.1016/S0140-6736(21)02143-7
Campiolo EL, Kubo EKL, Ochikubo GT, Batista G. Impacto da pandemia do COVID19 no Serviço de Saúde: uma revisão de literatura. InterAm J Med Health. 2020; 3:1–5. Doi: 10.31005/iajmh.v3i0.140 DOI: https://doi.org/10.31005/iajmh.v3i0.140
Saavedra PAE, Galato D, Silva CMS Silva ICR, Silva EV. Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018–2020). Front Pharmacol. 2022;13. Doi: 10.3389/fphar.2022.1028233 DOI: https://doi.org/10.3389/fphar.2022.1028233
Penha IN da S, Santos ALM, Marinho ACH de F, Alves LA. O uso de medicamentos controlados durante a pandemia da Covid-19 observado em uma drogaria na região do sudoeste baiano. RSD. 2021;10(16):1–8. Doi: 10.33448/rsd-v12i13.44204 DOI: https://doi.org/10.33448/rsd-v10i16.23752
De Oliveira LM, de Menezes Filho ACP, Porfiro CA. Uso da Passiflora incarnata L. no tratamento alternativo do transtorno de ansiedade generalizada. RSB 2020;9(11):e2349119487. Doi: 10.33448/rsd-v9i11.9487 DOI: https://doi.org/10.33448/rsd-v9i11.9487
Cordioli AV. Transtornos de Ansiedade. In: Duncan BB, Schmidt MI, Giugliani ERJ. Medicina ambulatorial: condutas de atenção primária baseadas em evidências, 3a ed. Porto Alegre: Artmed; 2004. p. 863-84. Disponible en: https://aps-repo.bvs.br/aps/quais-sao-os-sinais-e-sintomas-de-transtornos-de-humor-ansiedade-e-depressao-que-podem-ser-usados-em-uma-estrategia-de-rastreamento-populacional/
BRASIL. Ministério da Saúde. Secretária de Vigilância Sanitária. Portaria nº 344, de 12 de maio de 1998. Aprova o Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial. Diário Oficial [da] República Federativa do Brasil, Poder Executivo, Brasília, DF, 1998. Disponible en: http://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt02_05_1998_rep.html
BRASIL. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada n° 357, de 24 de março de 2020. Diário Oficial [da] República Federativa do Brasil, Poder Executivo, Brasília, DF, 2020. Disponible en: https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-357-de-24-de-marco-de-2020-249501721
Pereira RM. Planejamento, Programação e Aquisição: prever para prover. Em: Carvalho FD, Wannmacher L., organizadores. Uso Racional de Medicamentos: fundamentação em condutas terapêuticas e nos macroprocessos da Assistência Farmacêutica [Internet]. 1o ed Brasília: Organização Pan-Americana da Saúde/Organização Mundial da Saúde; 2016. Disponible en: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.rets.epsjv.fiocruz.br/sites/default/files/arquivos/biblioteca/fasciculo_10.pdf
Secretaria de Saúde do Distrito Federal. Relação de Medicamentos do Distrito Federal [Internet]. 2022. 1–82 p. Disponible en: www.saude.df.gov.br/reme-df/.
Organização Mundial da Saúde. ATC/DDD Index 2023 [Internet]. 2023. Disponible en: https://www.whocc.no/atc_ddd_index/
Rodrigues PS, Francisco PMSB, Fontanella AT, Borges RB, Costa KS. Uso e fontes de obtenção de psicotrópicos em adultos e idosos brasileiros. Ciênc saúde coletiva. 2020;25(11):4601–14. Doi: 10.1590/1413-812320202511.35962018 DOI: https://doi.org/10.1590/1413-812320202511.35962018
Rocha BS, Werlang MC. Psicofármacos na Estratégia Saúde da Família: perfil de utilização, acesso e estratégias para a promoção do uso racional. Cien Saude Colet. 2013;18(11):3291–300. Doi: 10.1590/S1413-81232013001100019 DOI: https://doi.org/10.1590/S1413-81232013001100019
Agrello MTN, Tavares GGP, Ribas AJ. Uso indevido de benzodiazepínicos, tentativas e ideações suicidas: reflexões a partir da prática. BJHP. 2021;3(2). Doi: 0.29327/226760.3.2-3 DOI: https://doi.org/10.29327/226760.3.2-3
Chisini LA, de Castilhos ED, Costa FDS, D’avila OP. Impact of the covid-19 pandemic on prenatal, diabetes and medical appointments in the brazilian national health system. Rev bras epidemiol. 2021;24. Doi: 10.1590/1980-549720210013 DOI: https://doi.org/10.1590/1980-549720210013
BMJ Best Practice. Transtorno bipolar em adultos [Internet]. 2023. Disponible en: https://soundcloud.com/bmjpodcasts/bipolar-disorder?
Fick DM, Semla TP, Steinman M et al. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–94. Doi: 10.1111/jgs.15767 DOI: https://doi.org/10.1111/jgs.15767
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Raissa Pereira Santos, Jessica Silva Teles Farrapo, Alexandre Vaz Machado, Alexandre de Souza Silva, Bábilla Nunes de Souza, Rafael Santos Santana, Rodrigo Fonseca Lima
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
